Cadre (CDRE) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $25.92, +0.58% vs the prior close of $25.77.
- Volume 513.80K shares, 1.1x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
CDRE rises 0.6% to $25.92. Closed at $25.92, +0.58% vs the prior close of $25.77. Day range $25.87–$26.68, opened at $25.99.
CDRE daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — CDRE rises 0.6% to $25.92
- Closed at $25.92, +0.58% vs the prior close of $25.77. Day range $25.87–$26.68, opened at $25.99.
- Volume was 513.80K shares, 1.1x its 50-day average of 468.12K.
- Price is -10.5% vs its 50-day average ($28.97) and -21.3% vs its 200-day average ($32.93).
- 52-week range $24.07–$48.76; today's close sits at 7% of that range, 46.8% below the 52-week high.
Oct 14, 2026 — CDRE dips 1.5% to $25.77
- Closed at $25.77, -1.45% vs the prior close of $26.15. Day range $25.25–$26.04, opened at $25.95.
- Volume was 431.50K shares, 0.9x its 50-day average of 467.71K.
- Price is -11.4% vs its 50-day average ($29.08) and -21.9% vs its 200-day average ($33.01).
- 52-week range $24.07–$48.76; today's close sits at 7% of that range, 47.1% below the 52-week high.
Oct 13, 2026 — CDRE rises 1.2% to $26.15
- Closed at $26.15, +1.20% vs the prior close of $25.84. Day range $24.97–$26.46, opened at $25.74.
- Volume was 627.70K shares, 1.4x its 50-day average of 463.31K.
- Price is -10.4% vs its 50-day average ($29.18) and -21.0% vs its 200-day average ($33.09).
- 52-week range $24.07–$48.76; today's close sits at 8% of that range, 46.4% below the 52-week high.
Oct 12, 2026 — CDRE jumps 5.3% to $25.84 on 1.8x normal volume
- Closed at $25.84, +5.25% vs the prior close of $24.55. Day range $24.25–$25.89, opened at $24.38.
- Volume was 837.60K shares, 1.8x its 50-day average of 454.12K — unusually heavy trading.
- Price is -11.7% vs its 50-day average ($29.27) and -22.1% vs its 200-day average ($33.18).
- 52-week range $24.07–$48.76; today's close sits at 7% of that range, 47.0% below the 52-week high.
Oct 9, 2026 — CDRE dips 1.1% to $24.55, a 52-week low on 2.0x normal volume
- Closed at $24.55, -1.13% vs the prior close of $24.83. Day range $24.07–$24.89, opened at $24.74.
- Volume was 877.10K shares, 2.0x its 50-day average of 443.56K — unusually heavy trading.
- Price is -16.4% vs its 50-day average ($29.37) and -26.2% vs its 200-day average ($33.26).
- 52-week range $24.07–$48.76; today's close sits at 2% of that range, 49.7% below the 52-week high.
- That makes 3 straight losses.
Oct 8, 2026 — CDRE dips 0.6% to $24.83, a 52-week low
- Closed at $24.83, -0.56% vs the prior close of $24.97. Day range $24.42–$25.00, opened at $24.84.
- Volume was 679.40K shares, 1.5x its 50-day average of 438.70K.
- Price is -15.8% vs its 50-day average ($29.49) and -25.5% vs its 200-day average ($33.35).
- 52-week range $24.42–$48.76; today's close sits at 2% of that range, 49.1% below the 52-week high.
Oct 7, 2026 — CDRE dips 2.1% to $24.97, a 52-week low
- Closed at $24.97, -2.08% vs the prior close of $25.50. Day range $24.57–$25.49, opened at $25.24.
- Volume was 496.70K shares, 1.1x its 50-day average of 437.34K.
- Price is -15.7% vs its 50-day average ($29.61) and -25.3% vs its 200-day average ($33.43).
- 52-week range $24.42–$48.76; today's close sits at 2% of that range, 48.8% below the 52-week high.
Oct 6, 2026 — CDRE rises 2.0% to $25.50
- Closed at $25.50, +2.00% vs the prior close of $25.00. Day range $25.07–$25.93, opened at $25.27.
- Volume was 608.30K shares, 1.4x its 50-day average of 434.61K.
- Price is -14.4% vs its 50-day average ($29.78) and -23.9% vs its 200-day average ($33.51).
- 52-week range $24.42–$48.76; today's close sits at 4% of that range, 47.7% below the 52-week high.
Oct 5, 2026 — CDRE ends flat (+0.0%) to $25.00, 6 down days in a row
- Closed at $25.00, +0.00% vs the prior close of $25.00. Day range $24.45–$25.78, opened at $24.91.
- Volume was 443.90K shares, 1.0x its 50-day average of 433.47K.
- Price is -16.5% vs its 50-day average ($29.92) and -25.6% vs its 200-day average ($33.59).
- 52-week range $24.42–$48.76; today's close sits at 2% of that range, 48.7% below the 52-week high.
- That makes 6 straight losses.
Oct 2, 2026 — CDRE ends flat (-0.0%) to $25.00, a 52-week low, 5 down days in a row
- Closed at $25.00, -0.04% vs the prior close of $25.01. Day range $24.42–$25.70, opened at $25.28.
- Volume was 517.00K shares, 1.2x its 50-day average of 429.68K.
- Price is -16.8% vs its 50-day average ($30.04) and -25.8% vs its 200-day average ($33.67).
- 52-week range $24.42–$48.76; today's close sits at 2% of that range, 48.7% below the 52-week high.
- That makes 5 straight losses.
CDRE latest news & SEC filings
Every SEC filing by or about CDRE in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 30, 2026 · SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 26, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Kanders Warren B sold 44,655 shares at $32.28 (≈$1.44M) on Aug 25, 2026
- Kanders Warren B sold 55,345 shares at $31.54 (≈$1.75M) on Aug 25, 2026
- Kanders Warren B sold 65,431 shares at $33.20 (≈$2.17M) on Aug 24, 2026
- Kanders Warren B sold 34,569 shares at $33.65 (≈$1.16M) on Aug 24, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 25, 2026 · 144 — Notice of proposed sale (Form 144)
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Aug 24, 2026 · 144 — Notice of proposed sale (Form 144)
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Aug 19, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Williams Brad sold 104 shares at $34.34 (≈$3.57K) on Aug 17, 2026
- Williams Brad sold 88,638 shares at $33.24 (≈$2.95M) on Aug 17, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 17, 2026 · 144 — Notice of proposed sale (Form 144)
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Aug 7, 2026 · 8-K/A — Amended current report
Amended current report
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 6, 2026 · SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 5, 2026 · 10-Q — Quarterly report (unaudited financial statements for the quarter)
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $207.13M (prior year $157.11M) (+31.8% vs Jun 30, 2025)
- Net income: $11.41M (prior year $12.21M) (-6.6% vs Jun 30, 2025)
- Diluted EPS: $0.26 (prior year $0.30) (-13.3% vs Jun 30, 2025)
Aug 5, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 29, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 2.03 — Took on a new material debt or financial obligation.
Jun 23, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Kanders Warren B sold 50,000 shares at $27.43 (≈$1.37M) on Jun 22, 2026
- Kanders Warren B sold 25,000 shares at $27.86 (≈$696.50K) on Jun 18, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Jun 18, 2026 · SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Things to know before you trade CDRE
- Last results release: Aug 5, 2026 (8-K Item 2.02). Previous ones: May 11, 2026, Mar 10, 2026, Nov 4, 2025. Based on that rhythm, the next report is likely around Nov 4, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.29% (largest 5.3%).
- Liquidity: about 606.34K shares (≈$15.72M) trade per day on average.
- 52-week position: $25.92 vs a range of $24.07–$48.76 (7% of the range).
- Dividends: last ex-dividend date Jul 31, 2026 ($0.1/share); 4 payments in the past 12 months.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 20 sales; latest: Warren B Kanders sold 44,655 shares on Aug 25, 2026.
- Latest filings: 10-Q Aug 5, 2026; 8-K Aug 5, 2026; 8-K Jul 29, 2026.
- Share count: 42.82M shares outstanding (Jul 31, 2026), +5.3% vs a year earlier — notable dilution.
- Listing: NYSE · industry: Orthopedic, Prosthetic & Surgical Appliances & Supplies.
CDRE market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 25.99 | 26.68 | 25.87 | 25.92 | 513.80K |
| Oct 14, 2026 | 25.95 | 26.04 | 25.25 | 25.77 | 431.50K |
| Oct 13, 2026 | 25.74 | 26.46 | 24.97 | 26.15 | 627.70K |
| Oct 12, 2026 | 24.38 | 25.89 | 24.25 | 25.84 | 837.60K |
| Oct 9, 2026 | 24.74 | 24.89 | 24.07 | 24.55 | 877.10K |
| Oct 8, 2026 | 24.84 | 25.00 | 24.42 | 24.83 | 679.40K |
| Oct 7, 2026 | 25.24 | 25.49 | 24.57 | 24.97 | 496.70K |
| Oct 6, 2026 | 25.27 | 25.93 | 25.07 | 25.50 | 608.30K |
| Oct 5, 2026 | 24.91 | 25.78 | 24.45 | 25.00 | 443.90K |
| Oct 2, 2026 | 25.28 | 25.70 | 24.42 | 25.00 | 517.00K |
| Oct 1, 2026 | 25.00 | 25.49 | 24.68 | 25.01 | 424.40K |
| Sep 30, 2026 | 25.66 | 25.73 | 25.08 | 25.09 | 426.10K |
| Sep 29, 2026 | 25.98 | 26.02 | 25.21 | 25.53 | 574.20K |
| Sep 28, 2026 | 26.32 | 26.60 | 25.64 | 26.06 | 409.80K |
| Sep 25, 2026 | 26.29 | 26.83 | 26.05 | 26.39 | 453.80K |
| Sep 24, 2026 | 26.59 | 26.66 | 26.19 | 26.21 | 334.20K |
| Sep 23, 2026 | 26.48 | 27.26 | 26.15 | 26.70 | 507.90K |
| Sep 22, 2026 | 27.07 | 27.37 | 26.39 | 26.88 | 669.70K |
| Sep 21, 2026 | 26.57 | 27.25 | 26.12 | 26.63 | 719.90K |
| Sep 18, 2026 | 26.13 | 26.74 | 25.94 | 26.29 | 1.57M |
About Cadre
Cadre (CDRE) is listed on the NYSE and classified by the SEC under “Orthopedic, Prosthetic & Surgical Appliances & Supplies”. Its business address is in JACKSONVILLE, FL. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1860543.
CDRE board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Warren B Kanders | CEO AND CHAIRMAN | Aug 26, 2026 |
| Mary E. Kissel | Director | Jun 18, 2026 |
| Hamish Norton | Director | Jun 18, 2026 |
| William G Iii Quigley | Director | Jun 18, 2026 |
| Nicolas Sokolow | Director | Jun 18, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Blaine Browers | CHIEF FINANCIAL OFFICER | Jun 18, 2026 |
| Warren B Kanders | CEO AND CHAIRMAN | Aug 26, 2026 |
| Brad Williams | PRESIDENT | Aug 19, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Aug 25, 2026 | Warren B Kanders | Sale | 44,655 | $32.28 |
| Aug 25, 2026 | Warren B Kanders | Sale | 55,345 | $31.54 |
| Aug 24, 2026 | Warren B Kanders | Sale | 65,431 | $33.20 |
| Aug 24, 2026 | Warren B Kanders | Sale | 34,569 | $33.65 |
| Aug 17, 2026 | Brad Williams | Sale | 104 | $34.34 |
| Aug 17, 2026 | Brad Williams | Sale | 88,638 | $33.24 |
| Jun 22, 2026 | Warren B Kanders | Sale | 50,000 | $27.43 |
| Jun 18, 2026 | Warren B Kanders | Sale | 25,000 | $27.86 |
| Jun 17, 2026 | Warren B Kanders | Sale | 25,000 | $28.68 |
| Jun 16, 2026 | Warren B Kanders | Sale | 100,000 | $28.19 |
| Jun 15, 2026 | Warren B Kanders | Sale | 100,000 | $30.03 |
| Mar 23, 2026 | Warren B Kanders | Sale | 100,000 | $31.93 |
| Mar 20, 2026 | Warren B Kanders | Sale | 100,000 | $31.40 |
| Dec 12, 2025 | Blaine Browers | Sale | 20,435 | $43.79 |
| Dec 10, 2025 | Brad Williams | Sale | 24,000 | $42.99 |
CDRE financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $610.31M | $44.14M | 1.02 | $63.70M |
| Dec 31, 2024 | $567.56M | $36.13M | 0.90 | $31.78M |
| Dec 31, 2023 | $482.53M | $38.64M | 1.02 | $73.21M |
| Dec 31, 2022 | $457.84M | $5.82M | 0.16 | $46.41M |
| Dec 31, 2021 | $427.29M | $12.66M | 0.44 | $40.09M |
Latest balance sheet: total assets $917.30M, total liabilities $570.50M, cash $53.98M (as of Jun 30, 2026).
CDRE earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 5, 2026 | 8-K Item 2.02 (results) | $31.03 |
| May 11, 2026 | 8-K Item 2.02 (results) | $31.36 |
| Mar 10, 2026 | 8-K Item 2.02 (results) | $40.69 |
| Nov 4, 2025 | 8-K Item 2.02 (results) | $42.53 |
| Aug 5, 2025 | 8-K Item 2.02 (results) | $34.29 |
| May 6, 2025 | 8-K Item 2.02 (results) | $29.61 |
| Mar 11, 2025 | 8-K Item 2.02 (results) | $33.52 |
| Nov 6, 2024 | 8-K Item 2.02 (results) | $37.15 |
| Aug 9, 2024 | 8-K Item 2.02 (results) | — |
| May 7, 2024 | 8-K Item 2.02 (results) | — |
| Mar 5, 2024 | 8-K Item 2.02 (results) | — |
| Nov 8, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Orthopedic, Prosthetic & Surgical Appliances & Supplies
Intuitive Surgical (ISRG)Edwards Lifesciences (EW)Steris (STE)Zimmer Biomet (ZBH)Align Technology (ALGN)Smith & Nephew (SNN)MSA Safety (MSA)Establishment Labs (ESTA)Enovis (ENOV)Sanara MedTech (SMTI)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on CDRE
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.